Who
Steven Jon Russell
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Beta Bionics.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $391K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jan 2025
- Last trade
- 2 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $81K4,221 at $19.11 | filing |
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $81K4,221 at $19.11 | filing |
| 2 Jun 2026filed 3 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $53K4,222 at $12.61 | filing |
| 2 Jun 2026filed 3 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $53K4,222 at $12.61 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $13K1,026 at $12.36 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $13K1,026 at $12.36 | filing |
| 27 Feb 2026filed 13 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —91,520 at $0.00 | filing |
| 27 Feb 2026filed 13 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —91,520 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —109,105 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —58,749 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —58,749 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —109,105 at $0.00 | filing |
| 2 Dec 2025filed 16 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $30K1,025 at $29.34 | filing |
| 2 Dec 2025filed 16 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $30K1,025 at $29.34 | filing |
| 2 Sep 2025filed 4 Sep 2025 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $19K1,015 at $18.86 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $4,854285 at $17.03 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $12K660 at $18.15 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $1,75794 at $18.69 | filing |
| 27 Feb 2025filed 3 Mar 2025 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
| 27 Feb 2025filed 3 Mar 2025 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
Investor Notification: Beta Bionics ($BBNX) Investors Are Reminded to Contact BFA Law About the Ongoing Securities Fraud Class Action to Recover LossesBBNX · thesudburystar.com · 24 Oct 2026BBNX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNXBBNX · wallstreet-online.de · 22 Oct 2026BETA BIONICS, INC. (NASDAQ: BBNX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 3, 2026BBNX · prnewswire.com · 20 Oct 2026
0 headlines in the last 90 days name Steven Jon Russell; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.